- Home
- TTI vs NVCR Comparison
TTI vs NVCR Comparison
Compare TTI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TTI | NVCR |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TTI | NVCR |
|---|---|---|
| Price | $7.95 | $12.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $10.40 | ★ $28.08 |
| AVG Volume (30 Days) | 1.7M | ★ 1.8M |
| Earning Date | 05-28-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $655,353,000.00 |
| Revenue This Year | $4.17 | $7.72 |
| Revenue Next Year | $10.41 | $6.74 |
| P/E Ratio | $411.00 | ★ N/A |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $2.03 | $9.82 |
| 52 Week High | $12.54 | $20.05 |
Technical Indicators
Market Signals| Indicator | TTI | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 31.53 | 48.74 |
| Support Level | $6.88 | $10.86 |
| Resistance Level | $8.27 | $14.13 |
| Average True Range (ATR) | 0.49 | 0.96 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 0.42 | 16.08 |
Price Performance
Historical ComparisonAbout TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.